Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06361238 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Mar 31, 2026 to Mar 31, 2027 · Start date changed from estimate of Apr 30, 2024 to Nov 19, 2024 · Study sites: 0 to 1 · 2 morev2 Show 5 more changesShow less
    • Primary completion date: Mar 31, 2026 to Mar 31, 2027
    • Start date changed from estimate of Apr 30, 2024 to Nov 19, 2024
    • Study sites: 0 to 1
    • Completion date: Mar 31, 2027 to Mar 31, 2028
    • Eligibility criteria expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to clarify the preventive effect of perioperative liraglutide application on postoperative delirium in elderly patients with Type 2 diabetes undergoing cardiac surgery.
Trial Details
NCT Number NCT06361238
Lead Sponsor The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions Delirium, Postoperative
Enrollment 260 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov